Ergoteles’s Atrion Corp ATRI Stock Holding History

Ergoteles’s Portfolio ATRI Stock Details ATRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-300	Closed	-$209K	–	1670
2021 Q3	$209K	Buy	+300	New	+$199K	0.01%	967

Other funds holding ATRI

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Ergoteles's ATRI Position: Q4 2021 in Review

Ergoteles sold out of Atrion Corp (ATRI) in Q4 2021, closing a stake of 300 shares — an estimated $209K sold.

Ergoteles first reported a position in ATRI in Q3 2021 and held it in 1 quarter. The position peaked at $209K in Q3 2021. 124 funds tracked by Wall St. Rank hold ATRI as of Q4 2021.

Ergoteles reported no remaining Atrion Corp position as of Q4 2021 after selling out during the quarter.
Ergoteles sold 300 Atrion Corp shares in Q4 2021, an estimated $209K.
Ergoteles first reported a position in Atrion Corp in Q3 2021 and held it in 1 quarter.
Ergoteles's Atrion Corp position peaked at $209K in Q3 2021.
124 funds tracked by Wall St. Rank held Atrion Corp as of Q4 2021.

Based on Ergoteles's 13F filing for Q4 2021, filed 14 Feb 2022.